Effects of nateglinide and rosiglitazone on pancreatic alpha- and beta-cells, GLP-1 secretion and inflammatory markers in patients with type 2 diabetes randomized crossover clinical study
Glauce Cordeiro Ulhôa Tostes Maria Rosário Cunha; Rosa Tsumeshiro Fukui; Márcia Regina Silva Correia; Dalva Marreiro Rocha; Rosa Ferreira dos Santos; Maria Elizabeth Rossi da Silva
Diabetology and Metabolic Syndrome London v. 8, art. 1, 9 p., 2016London 2016
Localização: FM - Fac. Medicina (BCSEP 017 2016 )(Acessar)